Logo Logo Logo
  • Who We Are
    • About Adlon
    • Ethics and Compliance
  • Healthcare Professionals
    • Prescribing Responsibly
    • Ask Adlon Medical
    • Products
    • Research
  • Patients & Caregivers
    • Consideration for Use of Prescription Stimulant Medications
    • Storage and Disposal for Prescription Stimulant Medications
    • Ask Adlon Medical
  • Products
    • Adhansia XR
  • Newsroom
    • Press Releases
  • Policies We Support
  • Social Media
  • Contact
    • Ask Adlon Medical
Logo Logo Logo Logo Logo
  • Who We Are
    • About Adlon
    • Ethics and Compliance
  • Healthcare Professionals
    • Prescribing Responsibly
    • Ask Adlon Medical
    • Products
    • Research
  • Patients & Caregivers
    • Consideration for Use of Prescription Stimulant Medications
    • Storage and Disposal for Prescription Stimulant Medications
    • Ask Adlon Medical

  • Products

    • Adhansia XR

  • Newsroom

    • Press Releases
  • Policies We Support
  • Social Media
  • Contact
    • Ask Adlon Medical
Privacy Policy
Terms & Conditions
Ethics & Compliance
Do Not Sell My Information
Adlon Therapeutics logo
© Adlon Therapeutics L.P. All Rights Reserved. Adlon Therapeutics L.P. is a subsidiary of Purdue Pharma L.P.

Effective July 20, 2022, Adlon Therapeutics has discontinued the sale of Adhansia XR® (methylphenidate HCI) extended-release capsules. Please note, this was a business decision and was not based on any safety or effectiveness concerns. We encourage discussing alternative treatment options with your patients or healthcare provider. If you have any questions, please contact Adlon Medical Information by calling 888-827-0618 and selecting option 1.